Numerous targets have been identified to facilitate PD treatment, such as chaperones, protein Abelson (c-Abl), glucocerebrosidase-1 (GBA-1), calcium, neuromelanin, ubiquitin-proteasome system (UPS), neuroinflammation, mitochondrial dysfunction, and KP. The gene discussed is GBA1; the disease is Parkinson disease.